H1 2026 Earnings
Financial report interval: 2025.12.30 - 2026.06.30
Overview: SINOPHARM(01099) the Revenue is 326.39 B (+4.25%), Miss estimate;the EBIT is 9.555 B (-9.83%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
326.39B4.25%
328.91B5.06%
-2.52B0.81%
EBITExceed expectations
9.55B9.83%
9.08B14.29%
+0.47B4.46%
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf